News
It said that 95% of people with cystic fibrosis in England will now be eligible for modulator therapy. The new drug, also ...
Today, the Cystic Fibrosis Foundation announced an additional investment of up to $24 million in Prime Medicine to continue the development of a gene editing therapy for people with cystic fibrosis ...
Hundreds of people with cystic fibrosis are to be offered a once-a-day pill which has been hailed as “life changing” by ...
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of Goldman Sachs’ top healthcare stock picks. On July 1, the ...
NHS patients in England with cystic fibrosis will be among the first in Europe to access a new treatment for their condition, ...
NHS England » NHS to roll-out new ‘triple combination’ therapy for hundreds of children and adults with cystic fibrosis ...
A new once daily triple drug treatment for cystic fibrosis is set to be “immediately funded” by NHS England following recommendation from the National Institute for Health and Care Excellence (NICE).1 ...
Reimbursement authority NICE has backed routine NHS use of Vertex's once-daily triple therapy Alyftrek ...
Axtell spent 15 hours paddleboarding the gap between Bimini and Lake Worth Beach. Although stormy and hot weather made it ...
Taking a swing at cystic fibrosis, the “Spread Love” charity golf tournament is back in Montreal for its fourth year. Started by Montrealers Marco Gentile and Marco Colasurdo, the event supports the ...
Vertex Pharmaceuticals said on Tuesday its next-generation cystic fibrosis treatment has won European Union approval for a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results